Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines quality care and outcomes: Difference between revisions
No edit summary |
m (Jair Basantes de la Calle moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines quality care and outcomes to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines quality care and outcomes) |
(No difference)
|
Latest revision as of 21:22, 5 December 2022
Intern Survival Guide |
Unstable angina / NSTEMI Microchapters |
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
Special Groups |
Diagnosis |
Laboratory Findings |
Treatment |
Antitplatelet Therapy |
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
Mechanical Reperfusion |
Discharge Care |
Case Studies |
Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines quality care and outcomes On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Maheep Sangha, M.B.B.S.
Overview
The measurement of quality and quality improvements initiatives are important in finding and utilizing the best management strategies in the setting of unstable angina and NSTEMI.
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update) (DO NOT EDIT)[1]
Quality Care and Outcomes (DO NOT EDIT)[1]
Class IIa |
"1. It is reasonable for clinicians and hospitals that provide care to patients with UA/NSTEMI to participate in a standardized quality-of-care data registry designed to track and measure outcomes, complications, and adherence to evidence-based processes of care and quality improvement for UA/NSTEMI.[2][3][4][5][6][7][8] (Level of Evidence: B)" |
References
- ↑ 1.0 1.1 2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR; et al. (2012). "2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 126 (7): 875–910. doi:10.1161/CIR.0b013e318256f1e0. PMID 22800849.
- ↑ Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators (2006). "Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial". Lancet. 367 (9510): 569–78. doi:10.1016/S0140-6736(06)68147-6. PMID 16488800.
- ↑ Bonow RO, Masoudi FA, Rumsfeld JS, Delong E, Estes NA, Goff DC; et al. (2008). "ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures". J Am Coll Cardiol. 52 (24): 2113–7. doi:10.1016/j.jacc.2008.10.014. PMID 19056002.
- ↑ Henry TD, Sharkey SW, Burke MN, Chavez IJ, Graham KJ, Henry CR; et al. (2007). "A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction". Circulation. 116 (7): 721–8. doi:10.1161/CIRCULATIONAHA.107.694141. PMID 17673457.
- ↑ Jacobs AK (2007). "Regional systems of care for patients with ST-elevation myocardial infarction: being at the right place at the right time". Circulation. 116 (7): 689–92. doi:10.1161/CIRCULATIONAHA.107.720946. PMID 17679610.
- ↑ Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM; et al. (2008). "ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction) Developed in Collaboration With the American Academy of Family Physicians and American College of Emergency Physicians Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine". J Am Coll Cardiol. 52 (24): 2046–99. doi:10.1016/j.jacc.2008.10.012. PMID 19056000.
- ↑ Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA; et al. (2008). "A citywide protocol for primary PCI in ST-segment elevation myocardial infarction". N Engl J Med. 358 (3): 231–40. doi:10.1056/NEJMoa073102. PMID 18199862.
- ↑ Ting HH, Rihal CS, Gersh BJ, Haro LH, Bjerke CM, Lennon RJ; et al. (2007). "Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol". Circulation. 116 (7): 729–36. doi:10.1161/CIRCULATIONAHA.107.699934. PMID 17673456.